I am currently taking Bumex (furosemide) and cannot tolerate Norvasc (amlodipine); what antihypertensive medication should I start?

Alternative Antihypertensive for Patients on Loop Diuretics with Calcium Channel Blocker Intolerance

Start an ACE inhibitor (such as lisinopril 10 mg daily) or an ARB (such as losartan 50 mg daily) as your first-line alternative antihypertensive agent when amlodipine is not tolerated in a patient already taking bumetanide.

Rationale for ACE Inhibitor or ARB Selection

The most recent ACC/AHA guidelines (2017) clearly establish that ACE inhibitors, ARBs, calcium channel blockers, and thiazide/thiazide-like diuretics are the four first-line antihypertensive drug classes with proven cardiovascular disease reduction 1. Since you cannot use amlodipine (a calcium channel blocker) and are already on bumetanide (a loop diuretic), this leaves ACE inhibitors or ARBs as your optimal choices 1.

The 2024 ESC guidelines reinforce that ACE inhibitors and ARBs combined with either dihydropyridine calcium channel blockers or diuretics represent preferred initial combinations, but when calcium channel blockers are not tolerated, the RAS blocker (ACE inhibitor or ARB) becomes the logical alternative 1.

Specific Drug Recommendations

First Choice: ACE Inhibitor

• Lisinopril 10 mg once daily is an excellent starting point 1
• Alternative ACE inhibitors include enalapril 5-10 mg daily or ramipril 2.5-5 mg daily 1
• ACE inhibitors provide once-daily dosing convenience and have extensive cardiovascular outcome data 1

Alternative if ACE Inhibitor Not Tolerated: ARB

• Losartan 50 mg once daily or candesartan 8-16 mg daily are appropriate alternatives 1
• ARBs are recommended specifically for patients who are ACE inhibitor intolerant (typically due to cough) 1
• Wait 6 weeks after discontinuing an ACE inhibitor before starting an ARB if there was a history of angioedema 1

Important Considerations with Loop Diuretic Use

Since you are already taking bumetanide, several monitoring parameters become critical:

• Monitor serum potassium closely when adding an ACE inhibitor or ARB, as both drug classes can increase potassium levels 1, 2
• The bumetanide label specifically warns that serum potassium should be measured periodically 2
• There is an increased risk of hyperkalemia, especially if you have chronic kidney disease 1
• Monitor renal function (creatinine/eGFR) at baseline and 2-4 weeks after initiation 1

Why Not Other Options?

Beta-Blockers

Beta-blockers are NOT recommended as first-line antihypertensive agents unless you have ischemic heart disease or heart failure 1. The 2017 ACC/AHA guidelines explicitly state this, as beta-blockers are less effective at preventing stroke compared to other first-line agents 1.

Additional Thiazide Diuretics

While thiazide or thiazide-like diuretics (chlorthalidone, hydrochlorothiazide, indapamide) are first-line agents 1, you are already on a loop diuretic (bumetanide). Loop diuretics are preferred over thiazides in patients with moderate-to-severe chronic kidney disease (eGFR <30 mL/min) 1. Adding a thiazide to your loop diuretic would only be considered for resistant hypertension requiring sequential nephron blockade 1.

Monitoring and Follow-Up

• Reassess blood pressure in 2-4 weeks after starting the ACE inhibitor or ARB 1
• Check electrolytes (particularly potassium) and renal function at 2-4 weeks 1
• If blood pressure remains uncontrolled, consider adding a thiazide-like diuretic (such as chlorthalidone 12.5 mg daily) to create a two-drug combination 1
• Target blood pressure should be <130/80 mmHg in most patients 1

Critical Contraindications to Avoid

• Do NOT combine an ACE inhibitor with an ARB - this combination is potentially harmful and not recommended 1
• Avoid ACE inhibitors/ARBs if you are pregnant or planning pregnancy 1
• Use caution if you have severe bilateral renal artery stenosis 1
• Do not use if you have a history of angioedema with ACE inhibitors (for ACE inhibitor selection) 1